首页> 外国专利> COMPOSITION FOR PREVENTING AND TREATING ACETAMINOPHEN-INDUCED HEPATOTOXICITY, CONTAINING TNP(N2-(M-TRIFLUOROBENZYL) AND N6-(P-NITROBENZYL)PURINE) AS ACTIVE INGREDIENTS

COMPOSITION FOR PREVENTING AND TREATING ACETAMINOPHEN-INDUCED HEPATOTOXICITY, CONTAINING TNP(N2-(M-TRIFLUOROBENZYL) AND N6-(P-NITROBENZYL)PURINE) AS ACTIVE INGREDIENTS

机译:预防和治疗由乙酰氨基酚引起的肝毒性的组合物,其中含有作为活性成分的TNP(N2-(M-三氟甲苯)和N6-(对硝基苯甲酰基)嘌呤)

摘要

The present invention relates to a composition for preventing and treating acetaminophen (AP)-induced hepatotoxicity, containing TNP(N2-(m-trifluorobenzyl) and N6-(p-nitrobenzyl)purine) as active ingredients. It is confirmed that TNP, which is known as an inhibitor for 5-inositol pyrophosphate, inhibits acetaminophen-induced cell death in human embryo stem cell-derived hepatocytes, mouse-derived hepatocytes and the human hepatoma cell line, increases reduced glutathione (GSH) concentration in hepatocytes, and inhibits phosphorylated JNK, which is a stress response increasing by acetaminophen, and it is also confirmed that the composition has the same protective effect against acetaminophen-induced hepatotoxicity as in the animal model, and thus TNP can be used as an active ingredient in the composition for preventing and treating acetaminophen-induced hepatotoxicity.
机译:本发明涉及一种用于预防和治疗对乙酰氨基酚(AP)引起的肝毒性的组合物,其含有TNP(N2-(间三氟苄基)和N6-(对硝基苄基)嘌呤)作为活性成分。已经证实,作为5-肌醇焦磷酸盐抑制剂的TNP抑制了对乙酰氨基酚诱导的人胚胎干细胞来源的肝细胞,小鼠来源的肝细胞和人肝癌细胞系中的细胞死亡,从而增加了谷胱甘肽(GSH)的还原。并抑制了磷酸化的JNK,这是对乙酰氨基酚增加的应激反应,并且还证实了该组合物具有与动物模型相同的对乙酰氨基酚诱导的肝毒性的保护作用,因此TNP可以用作组合物中的活性成分用于预防和治疗对乙酰氨基酚引起的肝毒性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号